Autres langues Beijing SL Pharmaceutical Co., Ltd.

Actions

002038

CNE000001L31

Produits pharmaceutiques

Cours en clôture Shenzhen S.E. 17/08/2026			Varia. 5j.	Varia. 1 janv.
6,170 ^CNY	+2,15%		+3,18%	-16,28%

01/06	Beijing SL Pharmaceutical Co., Ltd. approuve le versement d'un dividende en numéraire pour 2025	CI
07/05	Beijing SL Pharmaceutical obtient le feu vert réglementaire en Chine pour son médicament Xinfer	MT

Autres langues

01/06	Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2025
07/05	Beijing SL Pharmaceutical Gets China Regulatory Nod for Xinfer Drug
29/04	Beijing SL Pharmaceutical Co., Ltd. announces Annual dividend, payable on July 22, 2026
28/04	Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
28/04	Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
23/03	Beijing SL Pharmaceutical Co., Ltd.(XSEC:002038) dropped from FTSE All-World Index
26/10/25	Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
25/08/25	Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
23/05/25	Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2024
22/04/25	Beijing SL Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2024
21/04/25	Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
02/04/25	Beijing SL Pharmaceutical Secures Drug Registration for Regorafenib Tablets
25/10/24	Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024
25/08/24	Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024
01/07/24	Beijing SL Pharmaceutical Gets Nod to Market Epalrestat Tablets
28/06/24	Beijing SL Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 04 July 2024
21/06/24	Suzhou Pulekang Pharmaceutical Technology Co., Ltd announced that it expects to receive CNY 40 million in funding from Beijing SL Pharmaceutical Co., Ltd.
24/05/24	Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023
24/05/24	Beijing SL Pharmaceutical Co., Ltd. Announces Board Appointments
24/04/24	Beijing SL Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2023
23/04/24	Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
25/10/23	Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
20/10/23	Chinese Shares Extend Losses on Middle East Conflict; Beijing SL Pharmaceutical Slumps Despite Drug Trial Approval
20/10/23	Beijing SL Pharmaceutical Gets Nod to Trial Anti-Hepatitis C Drug; Shares Drop 10%
17/10/23	Kanghui Pharma Denies Speculations of Unit’s Involvement in Production of Weight-Loss Drugs